HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 503Generated: October 28, 2026
3-Chloro-1,2-dimethyl-1H-indol-5-amine → HCID 71698376, compound
https://huagongshe.com/reaction/503
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 3-Chloro-1,2-dimethyl-1H-indol-5-amine | HCID 89708648 | — |
| Reactant | 1-[[1-(2-Chloropyrimidin-4-yl)-3-methylpyrazol-4-yl]methyl]azetidin-3-ol | HCID 137357255 | — |
| Reagent | Potassium Carbonate | HCID 11430 | — |
| Catalyst | Palladium (II) acetate | HCID 4144353 | — |
| Catalyst | 2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenyl | HCID 11155794 | — |
| Solvent | 1,4-Dioxane | HCID 31275 | — |
| Product | HCID 71698376 | HCID 71698376 | 0% |
Reaction Steps
A 40 mL scintillation vial charged with 3-chloro-1,2-dimethyl-1H-indol-5-amine (53.6 mg, 0.28 mmol), 1-((1-(2-chloropyrimidin-4-yl)-3-methyl-1H-pyrazol-4-yl)methyl)azetidin-3-ol (70mg, 0.25 mmol), palladium(II) acetate (2.81 mg, 0.01 mmol), dicyclohexyl(2',4',6'-triisopropyl-[1,1'-biphenyl]-2-yl)phosphine (x--phos) (11.93 mg, 0.03 mmol) and Dioxane (3 mL) After being degassed by nitrogen bubbling , the reaction mixture was heated to 100 °C for 5 hours. LCMS analysis indicated no desired product and chloropyrimidine starting material was decomposed. The reaction mixture was discarded. Need to reverse the sequence.
Provenance & Evidence
| Source dataset | 750 AstraZeneca ELN dataset |
|---|
| ORD ID | ord-74a05ca9ab9042dbb66a38d995757deb |
|---|
| Source note | 750 AstraZeneca ELN dataset |
|---|